PainReform Provides Further Update on Phase 3 Clinical Trial of PRF-110

Stock Information for PainReform Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About PainReform Ltd.

PainReform Expands into Home Energy Management Sector, Leveraging DeepSolar's AI-Driven Platform to Address the Growing Solar Optimization Market
PainReform Provides Year-End Business Update
PainReform Completes Strategic Acquisition of DeepSolar, Unlocking New Growth Opportunities in AI-Driven Solar Analytics
PainReform Executes Definitive Agreement to Acquire DeepSolar, Marking a Unique Expansion Opportunity
PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial
PainReform Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders' Equity Requirement
PainReform Ltd. Confirms Sutures Compatibility in Human Clinical Trials for PRF-110
PainReform Announces Exercise of Warrants for $1.58 Million Gross Proceeds

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.